Significance of Beta Human Chorionic Gonadotropin in Predicting Disease Progression in Uterine Leiomyosarcoma
World Journal of Oncology · 2024-02 · 15 (1) · 143-148
DOI: 10.14740/wjon1748 ↗Kurz gefasst
Fallbericht in der Zeitschrift World Journal of Oncology, 2024-02. Verfasst von Abdulla Alzibdeh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
- Department of Pathology, King Hussein Cancer Center, Amman, Jordan.
- Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
- Faculty of Medicine, The University of Jordan, Amman, Jordan.
ORCID-Profile: Fawzi Abuhijla
Zitieren
APA
Alzibdeh, A., Mohamad, I., Al-Hussaini, M., Salah, S., Jaradat, A., Abuhijlih, R., & Abuhijla, F. (2024). Significance of Beta Human Chorionic Gonadotropin in Predicting Disease Progression in Uterine Leiomyosarcoma. World Journal of Oncology, 15(1), 143-148. https://doi.org/10.14740/wjon1748
Vancouver
Alzibdeh A, Mohamad I, Al-Hussaini M, Salah S, Jaradat A, Abuhijlih R, et al. Significance of Beta Human Chorionic Gonadotropin in Predicting Disease Progression in Uterine Leiomyosarcoma. World Journal of Oncology. 2024;15(1):143-148. doi:10.14740/wjon1748
BibTeX
@article{Alzibdeh2024,
author = {Alzibdeh, Abdulla and Mohamad, Issa and Al-Hussaini, Maysa and Salah, Samer and Jaradat, Abdalgani and Abuhijlih, Ramiz and Abuhijla, Fawzi},
title = {Significance of Beta Human Chorionic Gonadotropin in Predicting Disease Progression in Uterine Leiomyosarcoma},
journal = {World Journal of Oncology},
year = {2024},
volume = {15},
number = {1},
pages = {143--148},
doi = {10.14740/wjon1748}
}
EUVIMED